SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-03-31 18:15
Tx date 2025-03-31 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$33,494
+3,004 vol
$11.15 each 		56,350
Filed 2025-03-31 18:14
Tx date 2025-03-31 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
-6,008 vol 		53,346
Filed 2025-03-24 09:21
Tx date 2025-03-18 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+5,097 vol 		59,354
Filed 2025-03-14 16:22
Tx date 2024-12-31 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
+359 vol 		54,257
Filed 2025-03-14 16:20
Tx date 2024-12-31 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
+1,168 vol 		53,898
Filed 2024-03-28 08:48
Tx date 2024-03-27 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+6,438 vol 		52,730
Filed 2024-03-25 08:03
Tx date 2023-12-31 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
+440 vol 		49,814
Filed 2024-03-25 08:01
Tx date 2023-12-31 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
+1,444 vol 		49,374
Filed 2024-03-25 07:58
Tx date 2024-03-19 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+3,521 vol 		44,408
Filed 2024-03-25 07:56
Tx date 2024-03-19 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
-7,043 vol 		40,887
Filed 2023-06-11 17:33
Tx date 2023-06-09 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,000 vol 		47,930
Filed 2023-06-07 20:46
Tx date 2023-06-06 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,000 vol 		46,930
Filed 2023-03-31 17:59
Tx date 2023-03-31 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+7,219 vol 		45,930
Filed 2023-03-31 17:39
Tx date 2023-03-31 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+6,012 vol 		38,711
Filed 2023-03-31 17:38
Tx date 2023-03-31 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
-12,024 vol 		32,699
Filed 2023-03-27 09:42
Tx date 2022-12-31 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
+137 vol 		44,723
Filed 2023-03-27 09:37
Tx date 2022-12-31 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
+1,162 vol 		44,586
Filed 2022-04-03 18:40
Tx date 2022-03-31 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+5,721 vol 		43,424
Filed 2022-03-16 15:08
Tx date 2021-12-31 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
+858 vol 		37,703
Filed 2021-03-19 17:30
Tx date 2021-03-19 		$RX
BioSyent Inc. 		van der Mark, Joost
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+6,825 vol 		36,845